COVID-19诊断:从分子生物学到纳米材料
本文综述SARS-CoV-2诊断技术,涵盖RT-PCR、RT-LAMP、CRISPR-Cas等分子方法,ELISA、侧流免疫分析、化学发光等免疫学检测,以及影像学方法;指出现有方法分析性能良好但亟需低成本、简便的即时检测,纳米材料检测是重点探索方向。
要点
- 现有SARS-CoV-2诊断以分子扩增和免疫检测为主,影像学也用于辅助。
- 当前方法分析性能良好,但缺乏低成本、简便的即时检测方案。
- 纳米材料检测是应对上述未满足需求的重要探索方向。
核心结论
- 现有SARS-CoV-2诊断方法分析性能良好,但仍需低成本、简便的即时检测,纳米材料检测是潜在补充手段。
研究设计与样本
- 综述,讨论当前SARS-CoV-2诊断技术的实用性、局限性及纳米材料检测前景。
主要发现
- 分子方法包括RT-PCR、RT-LAMP等等温扩增及CRISPR-Cas基因编辑工具;免疫方法包括ELISA、侧流免疫分析、化学发光等;影像学方法也在使用。
临床怎么用
- 临床可依据现有分子、免疫及影像学方法诊断SARS-CoV-2,同时关注纳米材料即时检测的进展。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The SARS-CoV-2 pandemic has claimed around 6.4 million lives worldwide. The disease symptoms range from mild flu-like infection to life-threatening complications. The widespread infection demands rapid, simple, and accurate diagnosis. Currently used methods include molecular biology-based approaches that consist of conventional amplification by RT-PCR, isothermal amplification-based techniques such as RT-LAMP, and gene editing tools like CRISPR-Cas. Other methods include immunological detection including ELISA, lateral flow immunoassay, chemiluminescence, etc. Radiological-based approaches are also being used. Despite good analytical performance of these current methods, there is an unmet need for less costly and simpler tests that may be performed at point of care. Accordingly, nanomaterial-based testing has been extensively pursued. In this review, we discuss the currently used diagnostic techniques for SARS-CoV-2, their usefulness, and limitations. In addition, nanoparticle-based approaches have been highlighted as another potential means of detection. The review provides a deep insight into the current diagnostic methods and future trends to combat this deadly menace.
引用
- Perveen S, Negi A, Gopalakrishnan V, et al. COVID-19 diagnostics: Molecular biology to nanomaterials. Clin Chim Acta. 2022. PMID: 36403665. doi:10.1016/j.cca.2022.11.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。